Log in
Registration
Українська
English
Search for:
Home
Online Publication
Current Issue
Issue Archive
Authors
About
Information About the Journal
Focus and Scope
Indexing
For Authors
Submission Guidelines and Requirements
Peer Review
Article Processing Charges
Copyright and Licensing
Policies
Editorial Policy
Plagiarism Policy
Archiving Policy
Policy on the Use of Artificial Intelligence (AI) and AI-Supported Technologies
Open Access
Procedure for the Retraction of Published Articles
Ethical Issues
Publication Ethics
Procedure for Handling Complaints Regarding Ethical Breaches
Privacy Statement
International Standards and Principles of Operation
Organization of anticancer fight
Tumors of the chest cavity
Tumors of abdominal organs
Tumors of skin, soft tissues, bones
Breast tumor
Oncogynecology
Tumors of the head and neck
Oncurology
Oncohematology
Radiation diagnostics, radiation therapy
Experimental studies
Magazine online
All news
Author : Titorenko I.B.
Experience of using brentuximab vedotin in combination with chemotherapy for stage IV Hodgkin lymphoma in Ukraine
Authors: Kryachok I.A. Titorenko I.B. Moroz Yu.V. Aleksyk O.M.... Т. 15, №2 (58)
Experience of the treatment of NK-/T-cell lymphomas with SMILE regimens. Clinical case
Authors: Kryachok I. Aleksyk O.M. Titorenko I.B. Filonenko K.S. Т. 11, № 1-2 (41-42)
Modern approaches to the treatment of the extranodal NK/T-cell lymphoma
Authors: Kryachok I. Aleksyk O.M. Titorenko I.B. Filonenko K.S. T. 10, № 1-2 (37-38)
Hair cell leukemia: a literature review and a clinical case
Authors: Kryachok I. Titorenko I.B. Т. 9, № 3 (35) 2019
The role of PET in patients with relapsе and refractory of Hodgkin’s lymphoma
Authors: Kryachok I. Titorenko I.B. Т. 8, № 4 (32) 2018
Quality of life level in patients with diffuse large B-cell lymphoma from high-risk group treated with R-DA-EPOCH regimen
Authors: Filonenko K.S. Kryachok I. Stepanishyna Y.A. Martynchyk A.V.... №4(28) 2017
Brentuхіmab vedotin in the treatment of Hodgkin’s lymphoma
Authors: Kryachok I. Titorenko I.B. №2(26) 2017
MALT-lymphoma: etiology, pathogenesis, classification, clinical issues
Authors: Kryachok I. Ulianchenko K.O. Kadnikova T. Titorenko I.B.... №1(25) 2017
Survival comparison of patients with germinal and non-germinal center diffuse large B-cell lymphoma defined by Hans, Colomo and Muris immunohistochemistry algorithms. National Cancer Institute experience
Authors: Kryachok I. Martynchyk A.V. Filonenko K.S. Grabovyi A.N.... №1(25) 2017
Toxic hepatitis in patients with lymphoproliferative diseases
Authors: Kryachok I. Pastushenko J. Martynchyk A.V. Titorenko I.B. №4(24) 2016
Treatment of HIV-related non-Hodgkin’s lymphomas in the era of highly active antiretroviral therapy
Authors: Kryachok I. Skripets Т.V. Ulianchenko K.O. Titorenko I.B.... №3(23) 2016
Lymphoma and hepatitis C
Authors: Kryachok I. Ulianchenko K.O. Kadnikova T. Titorenko I.B.... №3(23) 2016
Primary mediastinal large B-cell lymphoma. The role of positron emission tomography
Authors: Stepanishyna Y.A. Kryachok I. Titorenko I.B. Filonenko Е.... №3(23) 2016
Palliative chemotherapy in patients with refractory and relapsed non-Hodgkin’s lymphomas and Hodgkin’s lymphoma
Authors: Kryachok I. Titorenko I.B. Kadnikova T. Pastushenko J.... №2(22) 2016
Granulocyte colony stimulating factor use during anticancer therapy
Authors: Kryachok I. Titorenko I.B. №3(19) 2015
1
2
»